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Immunological genomics of Brugia malayi: filarial genes implicated
in immune evasion and protective immunity
RICK M.MAIZELS1, MARK L.BLAXTER1 & ALAN L.SCOTT2
1Institute for Cell, Animal and Population Biology, University of Edinburgh, Edinburgh, UK and 2Department of Molecular Microbiology and
Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA
SUMMARY
Filarial nematodes are metazoan parasites with genome
sizes of > 100 million base pairs, probably encoding
15 000-20 000 genes. Within this considerable gene
complement, it seems likely that filariae have evolved a
spectrum of immune evasion products which underpin their
ability to live for many years within the human host.
Moreover, no suitable vaccine currently exists for human
filarial diseases, and few markers have yet been established
for diagnostic use. In this review, we bring together
biochemical and immunological data on prominent filarial
proteins with the exciting new information provided by the
Filarial Genome Project’s expressed sequence tag (EST)
database. In this discussion, we focus on those genes with
the highest immunological profile, such as inhibitors of host
enzymes, cytokine homologues and stage-specific surface
proteins, as well as products associated with the mosquito-
borne infective larva which offer the best opportunity for
an anti-filarial vaccine. These gene products provide a
fascinating glimpse of the molecular repertoire which
helminth parasites have evolved to manipulate and evade
the mammalian immune response.
Keywords filariasis, antigens, inhibitors, cytokine
homologues, vaccine
INTRODUCTION
Filarial nematodes enjoy one of the longest lifespans of
any human pathogen. Individual adult worms may live
for 7 years or more (1), and their microfilarial
offspring can remain in the bloodstream for at least
1 year (2). Their success implies highly effective
immune evasion strategies (3). With immunological
pathways becoming increasingly well defined, and with
the progress of the filarial genome project (4), it is
now possible to search for and characterize individual
molecules from these parasites which encode proteins
involved in neutralizing or evading the host immune
response. These may also serve as ideal vaccine or
drug targets.
One paradigm for immune evasion by pathogens has
been provided by work on viruses (5,6). Here, despite the
constraints of small genome size (, 200 kb) and limited
gene number (, 200), there are a remarkable series of
products which interfere with major histocompatibility
complex (MHC) Class I antigen processing, or which
mimic host cytokines or cytokine receptors. Nematode
parasites may adopt similar strategems, with two
interesting complexities. First, rather than capture immu-
nomodulatory genes from their hosts, nematodes may use
the genetic heritage they share with mammals, and adapt
conserved regulatory molecules for immune evasion (7,8).
As nematode genomes are relatively large (100 million
bp or more) and encode approximately 20 000 proteins,
the scope for expressing direct immune modulation
products is immense. Second, nematode parasites such
as the filariae can induce host cells to adopt a
suppressive function (9), perhaps providing the long-
term immunological tolerance thought to prevail in
infection (10,11).
Different approaches can be taken to identify immune
evasion genes. The classical path has been to character-
ize major products found at the host–parasite interface,
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such as surface and secreted molecules, which led to the
identification of antioxidant proteins on the filarial
cuticle (12). Second, we can probe for predicted gene
families by polymerase chain reaction (PCR), as used to
isolate a homologue of transforming growth factor
(TGF)-b (13). With the database of expressed sequence
tag (EST) sequences now exceeding 22,000, similar
searches can be done in silico and, from this route,
homologues of mammalian macrophage migration inhi-
bitory factor (MIF) have been discovered (7,14). Third,
we can use abundance alone as a measure of importance
leading us to discover novel genes with no precedent in
other infectious organisms (15,16). The completion of
the Caenorhabditis elegans genome (17) adds a
comparative dimension to these studies because immune
evasion genes would be expected to have diverged
sharply from homologues expressed in C. elegans or
even represent proteins altogether absent from the free-
living organism.
The rate of gene discovery in large parasite genomes
is rapidly accelerating, due to the success of EST
projects which perform large-scale sequencing of cDNAs
from multiple life cycle stages (18). For example, it is
estimated that approximately one-third of the predicted
20 000 genes in the filarial nematode Brugia malayi are
represented in at least one EST sequence (4,19). It is
essential that stock is taken regularly of the advances
offered by genome-based research, and that new
information is effectively integrated with both existing
and new protein-based analyses. The purpose of this
review is to summarize the most prominent and
promising filarial gene products in the realm of
immunology, focusing on those proteins most likely to
play a role in immune evasion and modulation on behalf
of the parasite, and/or most implicated as targets of the
immune response including those with potential for new
vaccines.
Filarial nematodes belong to the family Onchocerci-
dae (Table 1). Of several human pathogens, only B.
malayi can be readily maintained in laboratory animals,
and this species has consequently been studied in
greatest detail. Where comparisons can be made
between homologous genes from different species,
high levels of sequence conservation are generally
seen (13,20,21). It is valuable therefore to integrate
all available information from related species to
establish the function of novel proteins from these
parasites.
Table 2 lists a selection of B. malayi genes for
which full cDNA sequence is available and which are
implicated as important components that influence the
host immunological profile. Together with essential
information on each protein, we have also conducted a
virtual expression profile (4), enumerating the fre-
quency with which each transcript is represented in
EST sequences derived from each stage of the life
cycle. Thus, both stage-specific and constitutive genes
can be identified, and particular features from this
analysis are referred to under the respective gene
below. Table 3 summarizes the similarities of
Table 1 Gene and protein sequences from filarial nematodes in public databases (as of 8 January 2001)
Nucleotide sequences Protein sequences Protein structures ESTs
Human pathogens
Brugia malayi 517 153 3 22392
Onchocerca volvulus 581 256 0 13806
Wuchereria bancrofti 35 30 0 131
Animal models
Acanthocheilonema viteae (jird) 18 23 0 0
Brugia pahangi (jird/cat) 57 79 0 28
Dirofilaria immitis (dog) 61 64 0 0
Litomosoides sigmodontis (mouse) 14 15 0 198
Onchocerca ochengi (cow) 6 5 0 60
Other human parasites
Brugia timori 1 0 0 0
Loa loa 8 5 0 0
Mansonella perstans 1 0 0 0
Total 1329 641 3 36615
(including additional minor datasets)
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homologues from other filarial species, and from C.
elegans, where these are known. The main part of this
review discusses the categories of filarial proteins
thought to be important in the immunological interac-
tion between host and parasite. These genes are
summarized in Table 2.
ADULT SURFACE-ASSOCIATED PROTEINS.
Gp29 or Bm-GPX-1 (glutathione peroxidase)
The major surface-associated proteins of adult B.
malayi have been identified by molecular cloning.
The dominant noncollagenous component is a 29 kDa
glycoprotein designated gp29 (22) and subsequently
identified as a glutathione peroxidase, Bm-GPX-1 (12).
This enzyme has activity against lipid peroxides in
preference to hydroperoxide (23), and thus may protect
the lipid phase of the epicuticle from immune
reactive-oxygen intermediate attack. It may also have
a role in modifying or removing host immunomodu-
latory lipids (24). Thus, Bm-GPX-1 was the first
filarial product for which an explicit role was
proposed in defending parasites against host immunity.
However, there is no evidence as yet that host
responses against Bm-GPX-1 can protect against
infection because antibodies to this protein are present
in most infected individuals.
Bp-GPX-1 from Brugia pahangi shows an identical
amino acid sequence (25) while that from Wuchereria
bancrofti diverges by only 3% (20) (Table 3). However,
there are a number of synonomous nucleotide substitu-
tions, with introns diverging by 10% (B. malayi/B.
pahangi) and 28% (Brugia/Wuchereria). Curiously, no
homologue has been found in Onchocerca parasites. A
three-dimensional model is available in which the
Brugia GPX-1 structure has been predicted according
to the bovine homologue (26). The residues differing
between the filarial genera map to the exterior of this
model, consistent with either neutral drift of structurally
unconstrained amino acids, or variation at antigenically
significant positions.
Gp15/400 or NPA-1 (nematode polyprotein allergen)
Among the most intriguing components of the adult
nematode surface is gp15/400, a repeat-motif protein
with variable numbers of 15-kDa subunits, giving a
molecular weight range from 15 kDa to approximately
400 kDa (22,27). This polyprotein is related to
antigens from many different nematodes, including
the Ascaris body fluid allergen ABA-1 (28–30). The
gene family has thus been designated npa (nematode
polyprotein allergen/antigen) (31). Bm-NPA-1 is synthe-
sized as a 400 kDa precursor, containing regularly
spaced 132-amino acid subunits separated by tetrabasic
motifs. Incomplete cleavage of the primary translation
product at these tetrabasic sites is thought to yield the
characteristic ‘ladder’ observed on SDS-PAGE gels
(28,32). All known nematode genes for NPA proteins
contain 10 or more degenerate tandem repeats,
although the degree to which sibling repeats vary
within a single gene differs greatly according to
species (21).
Bm-NPA-1 is secreted by adult parasites (28,29), and is
a major target for immunoglobulin (Ig)E antibody
responses (33), indicating a prominent immunogenicity
in vivo. Filarial and other nematode NPA bind retinol
and fatty acids with high affinity. NPA-1 could be
considered to act as a ‘worm albumin’, perhaps
sequestering host signalling lipids (34). The Dirofilaria
immitis protein has also been reported to act as a
neutrophil chemotactic factor (35), indicating some form
of recognition by the innate immune system of a protein
which may perhaps be essential for worm survival in the
host.
Bm15 or Bm-CPI-2 (cysteine protease inhibitor-2)
Second in prominence to gp29 on the surface of adult
Brugia is a 15 kDa nonglycosylated surface protein,
Bm15 (36,37). This protein is also evident in parasite
secretions (37), and is present on the L3 surface. Once
cloned, its sequence revealed similarity to vertebrate
cysteine protease inhibitors or cystatins, and it has been
designated Bm-CPI-2 (cysteine protease inhibitor-2), in
distinction to the L3-specific cystatin Bm-CPI-1
described below (38). Close homologues of Bm-CPI-2
have been reported from Onchocerca volvulus (39,40)
and Acanthocheilonema viteae (41), and the latter
molecule directly inhibits T cell proliferation and
induces interleukin (IL)-10 release from murine macro-
phages (41).
The CPI-2 homologues from these three species
contain an intriguing 23-amino acid N-terminal extension
absent from all other members of the family. This
flanking sequence has been suggested to fulfil another
function, such as targetting for entry into host cells. If so,
Bm-CPI-2 would be a novel example in the evolution of
cystatins. A further point of interest is that EST
sequences for Bm-cpi-2 so far deposited reveal approxi-
mately equal numbers of two variants differing by a
single amino acid (Asn or Lys at residue 90). Such
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Table 2 B. malayi genes for which full cDNA sequence is available
Gene
BMC
cluster
Homologues
in other
cDNA
accession
Protein
length
Native MW
(Western)
EST abundance by stage (no. of sequences)
name aka number Identification species number (aa) (kDa) Mf L2 vL3 L3d6 L3d9 L4 YA AdF AdM Total Reference
Adult surface-associated proteins
api-1 Bm-33 04136 Aspartyl
protease
Av, Ce, L11001 233 33 4 0 7 0 0 0 0 1 8 20 (51)
inhibitor Di, Ov
cpi-2 Cystatin 01649 Cysteine
protease
Av, Ce, Ov AF015263 161 15/16 0 0 14 2 0 0 0 2 2 20 (38)
inhibitor-2
gpx-1 gp29 02584 Glutathione Bp, Ce, Di, X69127 223 29 2 0 0 0 0 7 1 2 14 26 (20)
peroxidase-1 Wb
far-1 Bm20 04112 Fatty acid and Ce, Ov U69169 179 20 0 2 3 0 0 1 1 0 4 11 (46)
retinol-binding
protein-1
nlt-1 Bm-24; 03432 Secreted Bp, Ce,Di, AF072679 211 24 0 0 31 1 0 0 3 0 4 39 (49)
Di22U-like protein Ov
npa-1 gp15/400
ladder
04904 Nematode
polyprotein
Bp, Di S76365 . 1000 . 200 0 0 1 0 0 0 0 0 0 1 (29)
pRUNG allergen-1
sod-2 ecSOD 00677 Superoxide
Dismutase
Bp, Ov X76283 199 24 1 1 2 0 0 2 0 2 1 9 (55)
(Cu/Zn)
tpx-1 00122 Thioredoxin Ce, Di, Ls, U34251 229 25/45 1 0 3 0 1 0 1 0 1 7 (60)
peroxidase-1 Ov
tpx-2 00211 Thioredoxin
peroxidase-2
Ce, Di, Ov U47100 199 22 1 1 57 0 0 10 0 13 1 83 Scott
et al.*
Microfilarial surface and secreted proteins
chi-1 Mf-1 00298 Chitinase Bp, Av, Ov M73689 504 70 8 1 0 0 0 0 0 1 1 11 (64)
chi-2 Mf-1 00762 Chitinase Bp, Av, Ov U59688 518 75 2 1 0 0 0 0 0 0 1 4 (64)
shp-1 Mf22 01695 Mf sheath
protein-1
Bp, Ls U43568 200 22 0 0 0 0 0 0 0 26 1 27 Hirzmann
et al.*
shp-2 01663 Mf sheath
protein-2
Bp, Ls Z35444 237 0 0 0 0 0 0 0 2 0 2 Hirzmann
et al.*
shp-3 00617 Mf sheath
protein-3
Bp, Ls AF030944 222 5 0 0 0 0 0 0 2 1 8 Hirzmann
et al.*
shp-3a 00617 Mf sheath
protein-3a
Bp, Ls AF030944 140 0 0 0 0 0 0 0 1 0 1 Hirzmann
et al.*
spn-2 Serpin 00328 Serpin-2 Ce AF009825 428 47·5 50 0 0 0 0 0 0 1 0 51 (78,79)
Larval proteins
alt-1 00123 Abundant
larval
Di, Ov, Wb U57547 125 20 0 0 35 0 0 0 0 0 0 35 (15)
transcript-1
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alt-2 00213 Abundant
larval
Bp, Ce, Di,
Ls, Ov, Wb
U84723 128 20 0 0 80 7 0 0 0 0 0 87 (15)
transcript-2
cpi-1 Cystatin 00178 Cysteine
protease
Av, Ce, Ov U80972 127 14 0 0 8 0 0 0 0 0 1 9 (15)
inhibitor-1
glt-3 alt-3 00136 Glycine
/tyrosine-rich
Ov U80974 55 6 0 0 16 0 0 0 0 0 0 16 (15)
transcript-3
glt-4 alt-4 00148 Glycine
/tyrosine-rich
R47625 73 0 0 10 0 0 0 0 0 1 11 (15)
transcript-4
lid-1 Av-L3
homologue
00031 LIM domain Av, Ov AA454417 566 2 0 15 5 1 1 0 2 0 26 Murray
et al.*
nlt-1 Bm-24;
Di22U-like
03432 Novel larval
transcript
Bp, Di,
Ov, Ce
AF072679 211 24 0 0 31 1 0 0 3 0 4 39 (49)
spn-1 Serpin 00322 Serpin-1 Ce U04206 392 1 0 26 1 0 0 0 0 0 28 (81)
sxp-1 BmM14 05831 Related to
RAL-2
and BmM5
Av, Bp, Ce,
Ls, Ov, Wb
M98813,
M95546
162 13 2 0 28 3 1 1 4 3 5 47 (98,99)
val-1 Asp 00351 Venom
allergen
like-1
Ce, Di,
Ov, Wb
AF042088 220 45 3 0 72 4 1 0 0 0 2 82 McCarthy
& Hopkins*
(95)
Cytokine/cytokine receptor homologues
mif-1 00238 MIF
homologue-1
Bp, Ce,
Di, Ov, Wb
U88035 115 12·3 0 4 3 0 0 18 1 8 7 41 (7)
mif-2 02968 MIF
homologue-2
Ce, Ov AY004865 120 12·8 1 0 0 1 0 0 0 1 0 3 (14)
tgh-1 11366 TGF-b
homologue-1
Bp, Ce AF012878 428 0 0 0 0 0 0 1 0 0 1 (13)
tgh-2 01513 TGF-b
homologue-2
Ce AF104016 349 12 4 0 0 0 0 2 3 4 5 18 (8)
tph-1 TCTP 00169 Tumour
protein
homologue-1
Ce U80971 181 24 15 2 5 1 0 11 0 8 22 64 (15)
trk-1 TGF-b
receptor
(type 1)-1
Bp, Ce AF013991 645 0 0 0 0 0 0 0 0 0 0 (107)
Total ESTs deposited in dbEST 2977 608 3249 1330 196 1529 1041 3335 4289 18743 (4)
*Unpublished data.
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evidence for coding polymorphisms remains rare among
filarial proteins.
The functions of Bm-CPI-2 present an instructive example
of how filarial proteins may interfere with the host immune
response. Sequence analysis reveals two potential active
sites, the universal papain-inhibiting motif common to Bm-
CPI-1 and -2, and a second SND-containing site, found in
Bm-CPI-2, which blocks enzymes of the legumain or
asparaginyl endopeptidase (AEP) clade (42). Interestingly,
an AEP is involved in the MHC class II antigen processing
pathway (43), and recent work has established that purified
recombinant Bm-CPI-2 can specifically inhibit AEP activity
and block the class II-dependent presentation of exogenous
antigen by human B cells (44).
Bm20 or Bm-FAR-1 (fatty acid and retinol binding
protein)
Surface labelling of adult B.malayi gives weaker and
variable iodination of a 20 kDa protein related to Ov20, a
much more prominent surface antigen on adult O. volvulus
(45). Including the conserved signal sequence, both Bm-
FAR-1 and Ov20, are 178 amino acids in length, but the
proteins differ in 26/160 amino acids (84% identity) over
the mature polypeptide (46). Three of these substitutions
replace asparagine residues found in Ov20, nullifying
potential glycosylation sites, and although one new site is
observed in Bm-FAR-1, this is thought not be used in the
native product.
While Ov20 is recognized by serum antibodies from
a high proportion of onchocerciasis patients (47), the
B. malayi homologue has a lower immunological
profile, and only marginal serological responses are
detected in lymphatic filariasis patients (46). However,
both Onchocerca (48) and Brugia (Allen & Kennedy,
personal communication) proteins show functional fatty
acid and retinol binding, and the gene has accordingly
been re-designated far-1. Because no NPA-1 homologue
has yet been found in O. volvulus, it may be that Ov-
20 is upregulated to provide a compensatory level of
retinol binding in the Onchocerca species.
Bm-24 or Bm-NLT-1 (novel larval transcript;
D. immitis-P22U-like)
In D.immitis, a secreted 22 kDa protein (Di-P22U) has
been isolated, antibodies to which react with a 24 kDa
surface-labelled protein from the L3 and L4 of B.
malayi; the same antigen is also weakly represented on
the adult parasite (49). Electron microscopy locates Di-
P22U to the cuticle and hypodermis of adult D.
immitis, but the protein is evidently obscured on the
surface because no binding is detected by immuno-
fluorescence assays on intact worms. Cloning of the B.
malayi homologue reveals a 211-amino acid protein
Table 3 Amino acid identities between key filarial proteins from different species
B. malayi
Length
C. elegans
Gene Protein (amino acids) B. pahangi W. bancrofti L. sigmodontis A. viteae D. immitis O. volvulus Presumed orthologue
alt-2 ALT-2 128 96·9% 87·0% 64·8% 64·8% 57·8% 46·6% 19·0% CO8A9
api-1 API-1 233 76·1% 75·2% 72·2% 41·5% F35A5·4
cpi-2 CPI-2 161 66·0% 65·0% 26·7% R01B10·1
far-1 FAR-1 178 83·8% 34·1% F02A9·2
gpx-1 GPX-1 223 100·0% 96·9% 74·0% 52·9% C11E4·1
mif-1 MIF-1 115 86·0% 93·0% 84·0% 85·0% 35·0% Y53A3A.3
mif-2 MIF-2 115 75·0% 38·0% C52E4·2
shp-1 SHP-1 200 90·0% 45·8%
sxp-1 SXP-1 153 30·0% 82·5% 43·0% 32·0% 58·9% 27·2% F57H12·2
tgh-1 TGH-1 428 99·1% 42·4% dbl-1 (T25F10)
tpx-1 TPX-1 229 49·0% 63·0% 60·0% 62·0% 65·0% R07E5·2
val-1 VAL-1 220 90·9% 63·3% 55·0% 17·8% T05A10·4
Percentage identities are calculated as exact matches between the B. malayi deduced protein sequence and that of the closest known homologue from
other filarial species. It is possible that some comparisons are not between true orthologues. Slightly different calculations can be reached depending
on the numbers of gaps permitted in alignments.
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with a typical signal peptide (49). This sequence
matches a highly expressed vector-derived L3 transcript
in the B. malayi EST database which has been
designated Bm-nlt-1 or novel larval transcript-1 (50).
So far, no insight has been gained into the biological
function of this product, and there are as yet no data
on immunological recognition by infected or immune
hosts.
Bm33 or Bm-API-1 (aspartyl protease inhibitor)
A minor protein observed by surface labelling adult
B. malayi is Bm-33, a 33 kDa protein with similarity to
the aspartyl protease inhibitor gene family (51). The
best characterized homologue is in O. volvulus, in
which the immunodominant Ov-33 antigen elicits strong
antibody responses in 96% of patients (52); similarly, a
high proportion of B. malayi-infected patients express
antibodies to Bm-API-1, particularly of IgG1 and IgG4
isotypes (16). Functionally, Ov-33 expressed in yeast
shows inhibition of the aspartyl protease pepsin (53),
and the presence of a 17-amino acid putative signal
peptide at the N-terminus of Ov-33 and Bm-33 indicates
that the product may be secreted by the filariae. Filarial
aspartyl protease inhibitors show between 20% and 25%
sequence identities to known inhibitors from nonfilarial
nematodes, such as Ascaris PI-3 (51) which have been
shown to interfere with a murine cathepsin E involved
in antigen processing (54). No immunological role for
the filarial aspartyl protease inhibitors has yet been
established, although it is plausible that a similar set of
host aspartyl proteases are physiological target of these
inhibitors.
Bm-SODs (superoxide dismutases)
Biochemical analysis of the antioxyradical defences of
B. malayi indicated the presence of superoxide
dismutase, a key enzyme in detoxification of reactive
oxygen intermediates produced by host granulocytes.
Two distinct Brugia SOD genes have been cloned (55).
One encodes an intracellular (cytoplasmic) SOD, while
the second is a secreted extracellular isoform. The
secreted SOD is found at the surface of adult
nematodes, and is identified as a low abundance
22 kDa product accessible to iodine labelling (56).
Together with GPX, SOD probably provides the
parasite with essential defence against reactive oxygen
species. Notably, adult Brugia are relatively resistant to
killing by superoxide compared to the microfilariae,
which do not express either GPX-1, nor the SOD genes
(57).
Bm-TPXs (thioredoxin peroxidases)
Thioredoxin peroxidases (TPXs) are a large family of
antioxidant proteins produced by organisms from all
kingdoms. The members of the TPX family have various
assignations such as thiol-specific antioxidants (TSA) (58),
peroxidoxins (PXN) (59), and natural killer cell enhancing
factor (NKEFA) (59). The antioxidant activity of TPX is
based on its ability to efficiently degrade H2O2 and alkyl
hydroperoxides, thus preventing the production of toxic
hydroxyl radicals that damage proteins, lipids and DNA
(59).
The Brugia EST database has revealed that, similar
to a majority of eukaryotic organisms, Brugia tran-
scribes two distinct classes of tpx genes. One class
includes both Bm-TPX-1 (25 kDa) and Bm-TPX-2
(22 kDa). Although only 55% identical in amino acid
sequence, both proteins contain two highly conserved
cysteine residues that correspond to Cys-47 and Cys-
170 of the prototype TPX from yeast (58). The second
class of tpx gene encodes Bm-TPX-3 (26 kDa) which is
approximately 20% identical in amino acid sequence to
Bm-TPX-1 and Bm-TPX-2 and lacks the conserved
Cys-170. While it has been demonstrated that a
recombinant form of Bm-TPX-1 is capable of protecting
DNA from oxygen-radical-induced damage (60), Bm-
TPX-2 and Bm-TPX-3 have not been tested for
biological activity. However, the orthologues of
Bm-TPX-2 and Bm-TPX-3 from O. volvulus have
been shown to have antioxidant activity (61,62). Bm-
tpx1 and Bm-tpx-2 have similar patterns of expression
with peaks of transcription in the vector-stage L3s and
in adult females (Table 2). Bm-tpx-3 appears to have a
much lower level of transcription with 3, 2 and 1 ESTs
from the microfilarial, male and female libraries,
respectively (data not shown).
The roles that the Brugia-derived TPXs play in the
immunobiology of infection have not been fully defined.
Bm-TPX-1, which is not secreted, contains a mitochondrial
localization signal. Presumably, this TPX functions to
protect cells from the endogenously produced toxic
byproducts of aerobic metabolism (60). Studies to define
the localization and function of Bm-TPX-2 and Bm-TPX-3
have not been carried out. However, Ov-TPX-2 is
associated with the surface of microfilariae where it may
serve to protect the parasite from host-derived oxidative
damage (62).
MICROFILARIAL SURFACE AND SECRETED
ANTIGENS
Microfilariae (mf) of lymphatic filarial nematodes (Brugia,
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Wuchereria) and certain other species (e.g. Litomosoides
sigmodontis) are enveloped in a sheath, separate from the
cuticle, which is derived from the eggshell in utero. The mf
are thought to retain their sheath within the mammalian
host, and to exsheath in the vector blood meal. Strictly,
surface antigens of the mf relate to the sheath components,
but surface-iodination reagents penetrate the sheath and
label cuticle proteins, some of which are also described
below.
Chitinases, MF-1, Bm-CHI-1/2
Surface iodination of B. pahangi mf labels a triplet of
proteins of approximately 70 kDa (36), while an mf-
reactive monoclonal antibody, MF-1, binds two bands of
this size in B. malayi mf (63). The smaller of the B.
malayi proteins, p70, was cloned first (64), and proved to
be a functional chitin-degrading enzyme with a pre-
ference for internal cleavage of chitin polymers. N-
terminal sequencing confirms that both p70 and the
larger p75 from B.malayi, and all three isoforms (p69,
p73, p76) in B. pahangi are closely related (65). The
structure of p70 (Bm-CHI-1) reveals a large catalytic
domain with close homology to eukaryotic and bacterial
chitinases, a mucin-like domain with three 14-amino acid
repeats rich in serine, threonine and acidic residues, and
a C-terminal 57-amino acid 6-cysteine domain. Southern
blot analysis later indicated that there are at least two
chitinase genes in B. malayi (66). A larger transcript,
containing an additional 14-amino acid repeat in the
serine/threonine-rich tract, was then isolated which may
encode p75 (65).
The catalytic domain is the only one with homology to
chitinases from bacteria, yeast and other metazoa.
However, many other chitinases include adjacent mucin-
like and cysteine-rich domains. For example, insect
chitinases contain C-terminal regions with six cysteine
residues which align closely to the Brugia sequence. This
arrangement, termed NC6/2, is also found in other
nematodes including C. elegans (67). Cysteine-rich
domains from other chitinases function to recruit and/or
hold chitin substrate to maximize activity (68). Such a
role is supported by findings that chitin binding by
recombinant Bm-CHI-1 is diminished when the C-
terminal noncatalytic segments are removed from the
protein (69).
The expression of Bm-CHI-1/2 shows an interesting
pattern. It is absent from adult worms and newborn mf,
but synthesis is initiated from 2 days after birth, and
reaches a plateau 2 weeks later (63,70). Because ‘imma-
ture’ mf are known to be incompetent at infection of
mosquitoes (63), the chitinases may play their role in
effecting transmission through the vector. Three possible
mechanisms have been suggested (70): degradation of the
mf sheath, a chitin-rich structure from which mf must
escape in the blood meal; breakdown of a chitin-contain-
ing barrier such as the peritrophic membrane in the
mosquito vector; or enzymatic release of chitobiose sugars
in the mosquito, blocking vector agglutinins from attack-
ing the parasite. As yet, none of these alternatives can be
excluded.
An immunological role for chitinases in the mamma-
lian host may also be important. Although in Brugia,
chitinase expression is mf-specific, the homologous
protein is prominent in A. viteae infective larvae
(71,72). Av-CHI-1 is strongly recognized by serum
antibodies from jirds vaccinated with irradiated L3 of
this species, and is not even expressed by mf (71).
Moreover, a homologue is also expressed in L3 of O.
volvulus, a species in which mf do not carry a sheath
(72).
The filarial chitinases are only distantly related to a
43 kDa chitinase reported to be recognized by humans
immune to W. bancrofti infection (73); subsequent cloning
(74) revealed a sequence most similar to the Rickettsial
organism Serratia, indicating that the L3-chitinase in
W. bancrofti is encoded by the endosymbiotic Wolbachia
(see below). It is interesting to consider that chitinase
expression may be essential for filarial L3 stages, but that
in W. bancrofti this requirement is fulfilled by the
endosymbiotic bacteria rather than by a filarial-derived
gene.
Major sheath proteins: Bm-SHP-1 or Mf-22 and
Bm-SHP-2
Following the identification of a major sheath protein,
Mf22, by Selkirk et al. (75), the Giessen group performed
a comprehensive analysis of filarial sheath proteins,
renaming Mf22 as SHP-1. Using L. sigmodontis as their
model, four further SHP proteins have been defined (76).
One of these additional products (Bm-SHP-2) has been
fully characterized from B. malayi (77), and SHP-3
homologues are present in the EST database. In general,
the mRNAs for these products are expressed only in the
female uterus.
One striking feature of SHP-1 is the extent of diversity
between the two Brugia species. While GPX-1 shows a
complete identity of amino acid sequence between these
two species (Table 3), Bm- and Bp-SHP-1 display over 10%
variation in amino acid sequence, including two indels
(Bp-SHP-1 has a GGA insertion at nt 79–81, the ATG
codon being 1–3; there follows a 42-nt tract almost
identical between the two species, and then a GGA
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insertion only in Bm-SHP-1. Thus the two sequences are of
identical length). Remarkably, analysis of the EST data
indicate that some of the B. malayi entries possess the
B. pahangi indel pattern. Although it is conceivable that
these represent two distinct genes, it remains an attractive
possibility that MF-22 displays a degree of polymorphism
or variation.
Bm-SHP-2 is a 236-amino acid protein containing
both proline-alanine tracts and a segment rich in
glutamines and tyrosines, the latter being suitable
substrates for cuticlin-like oxidative cross-linking (76).
In L. sigmodontis, three further sheath proteins have
been identified (SHP-3, -4 and -5), including compo-
nents exposed on the outermost layer of the mf sheath
(76). Homologues for SHP-4 and -5 have yet to be
found in B. malayi.
Serpin: serine protease inhibitors (Bm-SPN-1 and -2)
The most abundant microfilarial-specific transcript from
B. malayi encodes a serine protease inhibitor (serpin), a
428-amino acid 47·5 kDa protein found only in this
stage of the parasite. Bm-SPN-2 is homologous to
mammalian protease inhibitors such as a-1-antitrypsin,
but has no inhibitory activity against common serine
proteases such as trypsin, pancreatic elastase, or the
thrombin-cleaving enzymes (78). However, Bm-SPN-2 is
able to inhibit the activity of neutrophil elastase and
cathepsin G, two major proteases secreted by the most
abundant cell type in the blood, the habitat of the
microfilaria itself.
Bm-SPN-2 is the only antigen so far to have been
selected on the basis of strong stimulation of host T
cells (79), in distinction to others isolated by antibody
reactivity or mRNA abundance. Moreover, Bm-SPN-2
drives a response rarely seen in helminth infections,
dominated by a type 1 (Th1) phenotype. It is known
that live mf induce a relatively strong Th1-type
response in mice, in contrast to the adult and larval
stages which drive overwhelmingly Th2-like reactions
(80). Bm-SPN-2 is able to recall pure Th1 responses in
mf-primed cells, whereas even mf extract develops a
balanced response with both subsets represented (79).
The molecular basis for the Th1-bias in Bm-SPN-2
remains to be investigated.
In contrast, Bm-SPN-1 is expressed at a high level in
mosquito-derived larave, but minimally by any stages in the
mammalian host (81). Moreover, at a sequence level, Bm-
SPN-1 represents a very distinct branch of the family not
closely related to Bm-SPN-2 (82).
THIRD STAGE LARVAL ANTIGENS
Although surface-labelling data exist for Brugia infective
larvae (36,83), the surface antigens from this stage have
not been fully identified. Both cystatin proteins (Bm-CPI-1
and CPI-2) can be iodinated by surface-directed methods,
and are secreted by L3 maintained in vitro, while Bm-24
can also be identified in surface-iodinated L3 preparations
(49). A molecular approach to identify major L3 proteins
by mRNA or EST abundance indicates which proteins
may be required in quantity for invading parasites. Most
highly expressed overall are genes for Bm-ALT-2, Bm-
VAL-1 and Bm-ALT-1 (50); and among other prominent
transcripts are Bm-nlt-1, Bm-tpx-2, Bm-cpi-1 and Bm-spn-
1. Of these only Bm-alt-1/-2, Bm-cpi-1 and Bm-spn-1 are
trans-spliced with the conserved nematode 22-nt leader
sequence (15,81).
Bm-CPI-1 (cysteine protease inhibitor-1)
The first cysteine protease inhibitor to be identified in
Brugia was isolated from an analysis of highly
expressed trans-spliced mRNAs from the L3 stage
(15). Bm-cpi-1 expression, as revealed by a fine analysis
with mRNA taken at daily intervals throughout the life
cycle, is initiated in late L2 and L3 in the mosquito
vector, but terminates within 2 days of infection of the
mammalian host. In contrast, Bm-cpi-2 is constitutively
expressed at all stages of the parasite life cycle. Bm-
CPI-1 can be surface-labelled on the mosquito L3 and is
found in secretions. Bm-CPI-1 (similar to Bm-CPI-2) is
a good inhibitor of papain and cathepsin B, but the
physiological target of this product (whether in mos-
quito, mammal or within the nematode itself) has yet to
be defined.
Abundant larval transcripts (Bm-alt-1, -2)
In a strategy to identify parasite gene products required
for invasion and establishment in the mammalian host,
we set out to characterize those mRNAs from B.
malayi L3 which are highly expressed in mosquito-
borne infective larvae (15). The 5 0 spliced leader
sequence found on a proportion of nematode mRNAs
(84) was combined with an oligo-dT primer to PCR
amplify all trans-spliced transcripts (81, 85). Two
highly expressed genes were designated alt (abundant
larval transcript) -1 and -2 (15). The corresponding
proteins are closely related (79% amino acid identity)
small proteins of 125–128 amino acids. An acidic tract
near the N-terminus contains most of the variation
between the two polypeptide sequences. Significantly,
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alt mRNA expression is essentially limited to the larval
stages, and is not detectable in Mf or adult worms
(16).
The Filarial Genome Project provides an independent
assessment of the abundance of these two products
(18,19). alt-2 represents . 3% of all L3 ESTs, and alt-1
approximately 1·5% (50). The ALT-1/-2 proteins are
stored in the oesophageal gland of B. malayi L3 (Wu et
al., personal communication), and are secreted by larvae
when cultured following recovery from mosquitoes
(Murray and Maizels, unpublished data). Such prominent
expression implies a critical role in parasite entry into the
host. We therefore tested Bm-ALT-1 for its ability to
vaccinate jirds (Meriones unguiculatus) against B. malayi
L3 challenge. Immunization resulted in a 76% reduction
in worm load, the highest yet reported for a recombinant
filarial antigen (16).
The alt gene family is also conspicuous in other filarial
nematode species (50). In D. immitis, the Di20/22L protein
is found in the L3 ES and is strongly recognized by sera
from immune dogs (86). In O. volvulus, alt transcripts
comprise 4·6% of L3 mRNA, anti-ALT-1 antibodies stain
the glandular oesophagus, and Ov-ALT elicits partial
protection in mice (87). alt-1 also ranks highest in
abundance among transcripts from L3 of L. sigmodontis
(50), and an A. viteae homologue (Av18) figures strongly in
material released by moulting L3s (88). The Brugia EST
dataset includes a number of other ALT-related gene
transcripts suggesting that the gene family may be
significantly larger in some filaria (Gregory et al.,
unpublished). Thus, across the range of species, ALT
proteins are important candidates for a specific vaccine
against filarial infection (16).
Glycine-tyrosine rich abundant transcripts
(Bm-glt-3, -4)
Additional highly expressed trans-spliced transcripts from
L3 are two genes originally assigned Bm-alt-3 and -4 (15).
Because their sequence is not related to the alt-1/-2 family,
these genes have been redesignated Bm-glt-3 and -4.
Detailed expression profiling of Bm-glt-3 around the filarial
life cycle shows it to be initiated midway through the
mosquito phase, during L2, and terminated immediately
following infection; there is no expression by mature
mammalian stages (Gregory and Maizels, unpublished
data). Similar to the ALT proteins, there is no indication
of the functions of the putative GLT proteins. However, 11
homologous genes exist in C. elegans, in two arrays each
containing five copies, plus a single additional copy, all on
chromosome 5 (Gregory, unpublished data). This evidence
for gene multiplication implies an important functional
role, possibly conserved between free-living and filarial
nematodes.
Bm-LID-1 (Ov-L3 homologue)
An interesting antigen was isolated from the L3 of
O. volvulus by screening a cDNA library with serum
from a human volunteer vaccinated with irradiated L3
larvae (89). This clone, initially termed Ov-L3-1, encodes a
protein with a LIM domain, a motif identified in a variety
of vertebrate genes, including those encoding certain
adhesion proteins and transcription factors. The full-length
Brugia homologue, Bm-LID-1, contains 588 amino acids
with six potential N-linked glycosylation sites and multiple
CxxC motifs (Murray & Maizels, unpublished data). There
is no typical signal sequence and, in O. volvulus at least,
the mature protein is relatively insoluble, arguing that LID-
1 is not a secreted protein. However, Bm-lid-1 is relatively
highly transcribed by B. malayi L3, and this elevated
expression may account for the strength of the immune
response.
Venom allergen-like protein, Bm-VAL-1 (also known
as Ancylostoma secreted protein homologue)
A prominent transcript among ESTs from B. malayi L3 (18)
is a member of an expanding gene family for which the
prototype is Ancylostoma secreted protein (ASP), first
identified in the hookworm Ancylostoma caninum (90). The
Ancylostoma ASP is a front-running vaccine candidate
against canine hookworm. Subsequently, related genes have
been identified in a range of other nematode species,
including products which block neutrophil activation (91)
and induce angiogenesis in mice (92).
Members of this family have either single (approxi-
mately 200 amino acids) or double (approximately 400
amino acids) homology units, preceded by signal
sequences. In C. elegans there are at least 20 homologous
genes, only one of which has a double-domain structure
(93,94). Because the asp gene name in C. elegans is
assigned to an aspartic protease, the filarial gene is
designated Bm-val-1.
The full sequence of the ASP-like B. malayi homologue
contains a single consensus domain (95). Bm-val-1
transcripts are the second most-abundant among ESTs
from the vector-borne L3 stage, but are poorly represented
in cDNA libraries from other points in the life cycle (50).
However, a finer analysis using first-strand cDNA taken at
daily intervals revealed intermittent expression by mature
mammalian stages, including adult parasites (95), so that
Bm-val-1 is not stringently stage-specific in its expression.
Perhaps reflecting this, human antibody responses to
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Bm-VAL-1 noted in most infected patients include a
substantial IgG4 component in addition to IgG1 and IgG3
(95).
Bm-SXP-1
Bm-SXP-1 (the gene name is not an acronym) is not larval-
specific as it was first isolated as an immunodominant clone
from a male cDNA library. SXP-1 was subsequently
shown to be useful as a serodiagnostic reagent for
patients with patent infections with lymphatic filariasis,
including infections with W. bancrofti (96,97). Bm-SXP-1
is a member of a nematode-specific family of proteins
that are 12–14 kDa in mass and are distinguished by a
highly conserved motif structure (98). There is a high
level of serological reactivity to Bm-SXP-1 by lymphatic
filariasis patients (99), predominantly of the IgG4
isotype, and a percentage of patients with patent O.
volvulus and Loa loa infections also recognize Bm-SXP-
1 (96,97). Based on the utility of Bm-SXP-1 to diagnose
patent infections, it would be predicted that the
expression profile would show enhanced transcription at
the microfilarial stage. The EST database suggests that,
while it is transcribed by all of the stages present in the
vertebrate host, the highest levels of transcription may be
by the L3s (Table 2). Interestingly, gerbils immunized
with Bm-SXP-1 showed substantial reduction (up to 97%)
in microfilarial numbers, as well as a partial reduction
(approximately 35%) in adult numbers following L3
challenge (100). Although the lower adult worm burden
did not reach statistical significance, this outcome
suggests that Bm-SXP-1 may be a suitable target for
immunoprophylaxis against multiple stages of the filarial
parasite.
CYTOKINE AND CYTOKINE RECEPTOR-LIKE
PROTEINS
Three gene families have been discovered in filarial
nematodes with similarities to mammalian cytokines, two
of which (MIF and TGF-b) are likely to be of major
importance in the host–parasite relationship, while the
third [tumour protein homologue (TPH) or translationally
controlled tumour protein (TCTP)] is of less certain
significance. In the case of both MIF and TGF-b
families, two homologues from B. malayi have been
isolated. However, the same gene families are represented
in C. elegans (although with different expression
patterns), and the question is being addressed of whether
the filarial homologues fulfil physiological roles for the
nematode or immunological roles for the parasitic mode
of life.
MIF: Bm-MIF-1 and -2
The macrophage migration inhibitory factor (MIF) gene
family, derived from an ancient metazoan ancestor,
encodes small (approximately 115-amino acid) proteins
with many surprising features (101). For example, these
proteins are secreted despite lacking a signal sequence,
activate target cells through no known receptor, and
display an unusual enzymatic activity dependent upon a
proline at residue 2. Within the mammalian immune
system, MIF has generally been considered a pro-
inflammatory cytokine, but very recent work indicates
that, dependent upon dose, MIF can equally exert a
counter-inflammatory effect (102).
The EST database for B. malayi contains two distinct
MIF homologues which encode proteins secreted by
parasite (7,14,18). At the amino acid level, Bm-MIF-1 is
40% identical to human MIF and only 27% identical to
Bm-MIF-2; the latter shares 28% of residues with the
human homologue. Despite these differences, the three
molecules show very similar cytokine-like activity (e.g.
macrophage kinesis, monocyte activation and induction of
endogenous cytokine secretion) as well as the enzyme
activity (dopachrome tautomerase). We have also deter-
mined the crystal structure of Bm-MIF-2, which despite
being only 28% identical to human MIF, presents a
highly similar trimeric three-dimensional structure (14).
The active site combines residues from adjacent mono-
mers, so that trimerization is essential for biological
function.
The function of parasite-derived MIF molecules is indeed
a controversial question. In most in-vitro assays, Bm-MIFs
replicate the activity of human MIF, presenting a conun-
drum: why should a filarial parasite, intent on avoiding an
inflammatory tissue reaction, secrete MIF homologues
which are thought to amplify the inflammatory pathway?
Currently, we favour the hypothesis that continuous
secretion of MIF molecules by parasites may induce a
counter-inflammatory phenotype, either by densensitization
or by exposing host macrophages to a dose or duration of
MIF not reproduced in vitro. Such a hypothesis may also
explain the generation of ‘alternatively activated macro-
phages’ in filarial infections, which exert counter-inflam-
matory effects such as suppression of lymphocyte
proliferation (9,103,104). Recent results in mice repeatedly
exposed to recombinant Bm-MIF do indeed indicate that
macrophages are induced to differentiate into a novel
phenotype by the parasite molecule (Falcone et al.,
unpublished). If so, then the Bm-MIFs represent gene
products which modulate the host immune system by
recruiting and driving host cells into a more ‘suppressive’
mode.
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TGF-b family members (Bm-TGH-1 and -2)
The transforming growth factor-b superfamily includes a
diverse set of intercellular signalling molecules controlling
embryonic patterning and tissue differentiation, as well as
regulation of immune responses. The morphogens are
represented by Drosophila decapentaplegic (DPP) and
mammalian bone morphogenetic proteins (BMPs), while
the cytokine-like TGF-bs constitute a distinct subfamily
with an additional conserved cysteine in the mature protein
(105). In the mid-1990s, it was established that TGF-b
family members were involved in C. elegans development
(106). This prompted us to predict that Brugia would
express similar proteins, and to hypothesize that at least one
form in the parasitic nematode would be secreted to down-
regulate host immune cell responses.
Searching first by degenerate polymerase chain reaction,
and then from Brugia EST sequences as they became
available, two distinct TGF-b homologues have been
characterized. Almost identical tgh-1 genes were isolated
from B. malayi and B. pahangi, which fall into the DPP/
BMP subfamily by sequence similarity. The 428-amino
acid protein contains a C-terminal homology domain
corresponding to the mature 102-amino acid active product.
This domain shows 62% amino acid identity to C. elegans
DBL-1, 54% to DPP and 45% to mouse Nodal, a
differentiation-inducing protein. Transcription is relatively
low but peaks at periods surrounding growth in the
mammalian host. However, expression is absent from the
arrested microfilarial stage (13). This expression pattern,
and the sequence analysis, suggested that Bm-TGH-1 plays
a role in the maturational physiology and growth of the
filarial nematode.
A second TGF-b homologue, designated TGH-2, has since
been isolated from the EST dataset (8). The active domain
contains an additional cysteine, as found in mammalian TGF-
bs as well as other members of this subfamily (which include
myostatin, a muscle-inducer in vertebrates as well as the C.
elegans dauer-controlling product DAF-7). Bm-TGH-2 has
properties which are more likely to represent a parasite
immunomodulator: it is expressed by all stages resident in the
mammal, especially by the microfilariae. Becuase this stage
is devoid of developmental activity, such a pattern is
inconsistent with a morphogen. Moreover, it is secreted by
cultured adult and microfilariae of B. malayi, suggesting a
role in the interaction with the host (8). Preliminary assays
show a low but consistent level of binding to host TGF-b
receptors.
TGF-b acts on cells through a heterodimeric receptor. In
vertebrates and insects, a type II receptor chain ligates
TGF-b, and phosphorylates the type I receptor, leading to a
signal transduction cascade. The two receptors are related
but quite distinct in their phosphorylation sites, and because
the type I receptor may signal independently in some
instances, it is throught to be the ancestral gene. The Brugia
type I receptor has been cloned by PCR (107) but, despite
repeated efforts, no type II receptor has been identified. A
type II receptor, with recognizable homology to mamma-
lian type II receptors, exists in C. elegans (DAF-4). Thus,
the question remains open as to whether Brugia uses
classical TGF-b signalling pathways or has reverted to a
simplified, one-subunit receptor system.
Bm-TPH-1 (tumour protein homologue/histamine
releasing factor)
One of the abundant transcripts found in infective larvae
is homologous to a proposed mammalian cytokine,
histamine releasing factor (15). However, the identical
sequence has been recorded as TCTP. In Brugia, this
gene is transcribed throughout the life cycle (38). It is
also secreted by the adult parasite, indicating that it may
be available to play a role in the host–parasite
interaction. Experiments to ascertain whether Bm-TPH-1
can stimulate histamine release from human mast cells
have so far given negative results (Falcone, personal
communication).
A BROADER IMMUNOLOGICAL PROFILE OF
FILARIAE
The full genetic complement?
The approximately 22 000 ESTs from B. malayi represent
about 8800 different genes. Of these, approximately 55%
have no significant similarity (a BLASTX score prob-
ability greater than e-10) to either C. elegans proteins,
other known nematode proteins, or to any other sequences
from other organisms represented in GenBank. This
dataset is sufficiently extensive that comment can be
passed on those gene families which are conspicuous by
their absence. For example, catalase is not represented in
B. malayi, although a catalase-like activity has been
shown to protect adult and mf from hydrogen peroxide-
induced damage (57). Interestingly, this enzyme is
encoded in O. volvulus by the endosymbiotic Wolbachia
(108). A similar contrast is with infective larvae of
Toxocara canis, in which 6% of cDNAs encode a secreted
C-type lectin (109), and yet not one member of this major
gene family appears in the 20 000-strong B. malayi EST
dataset.
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Wolbachia antigens and lipopolysaccharides (LPS)
The filarial nematodes harbour an intracellular rickettsia-
like bacterium related to the Wolbachia reproductive
parasites of arthropods. The Wolbachia endosymbionts
from B. malayi and O. volvulus have been selected for
genome sequencing, and whole-genome clone maps have
been built for B. malayi. The genomes are approxi-
mately 1 Mb in size, and are likely to encode 2–3000
protein products. While many may be involved in the
bacterium–nematode interaction, some rickettsial pro-
teins could exert effects at the nematode–mammal
interface. Such products would be excellent candidates
for new drug targets. Tetracycline has a significant effect
on both B. malayi and L. sigmodontis in animal
infections, resulting in reduced nematode survival and
abrogation of fertility, while doxycycline has been
trialled in human onchocerciasis with significant effect
(110). Importantly, antibiotics known not to affect
rickettsiae have no effect on worm survival, and
nematode species that do not harbour bacteria are not
affected by antibiotic treatment. The early IL-1 response
of immune cells to crude antigens prepared from B.
pahang has the hallmarks of an antilipopolysaccharide
response, and can be abrogated by pretreatment with
polymixinB, an anti-LPS agent. LPS is a cell wall
product unique to bacteria, and thus the bacterial
genome may be driving some of the response to the
nematode (19,111–114).
Non-peptide antigens
Attention has increasingly focused on protein molecules
because of the wealth of sequence information and the
technical ease of expression and analysis of peptide
products. However, it would be a mistake to ignore
nonpeptide antigens. An important nonprotein component
expressed by filarial nematodes is phosphorylcholine (115–
117), which is secreted by adult filariae (116) and forms the
basis for the first circulating antigen test for bancroftian
filariasis.
Phosphorylcholine may play a significant immunomo-
dulatory role. First reports that phosphorylcholine-con-
jugates from B. malayi cause reduced T cell proliferation
(118), have been followed by detailed studies on ES-62,
a secreted phosphorylcholine-containing antigen from A.
viteae which downregulates signalling in both T cells
(119) and B cells (120) and induces dendritic cells
towards a type 2 phenotype (121). ES-62 contains
phosphorylcholine linked through a novel N-linked
glycan (122,123), while in B. malayi phosphorylcholine
is O-linked (116).
Other protein modifications, especially glycosylation,
are likely to have a major bearing on the immunological
response to filarial antigens. For example, certain strains
of mice are unable to recognize Bm-NPA-1 (gp15/400) or
Bm-GPX-1 (gp29) in their native, glycosylated state
(124); however, immunization with nonglycosylated
bacterially expressed forms of these antigens restores
responsiveness to ‘nonresponder’ strains (30,125).
Although glycosylation per se was not shown to be
responsible for these observations, this work illustrated
that post-translational modifications of products may
profoundly influence the immune response to individual
filarial antigens.
CONCLUSIONS
Parasite immunology has been transformed by the mole-
cular insights and precise tools offered from genome-led
research. The filarial genes we discuss here include some of
the most important players in successful parasite establish-
ment in the immunocompetent host, but there are likely to
be many more products to be discovered. Although the first
generation of these filarial proteins is dominated by
homologues of known gene families, for which gene
function can quickly be deduced, there is bound to be an
increasing emphasis on genes of unknown function, such as
the filarial alts, particularly where they have diverged
greatly from sequences in the free-living comparator,
C. elegans. A further dimension which now needs to be
assessed is how variable are different populations and
strains of the filarial parasites, a question which can be
asked with precision at the level of individual defined
genes.
The new filarial molecular biology is likely to have
a sweeping impact on research into and management of
filarial disease. For example, the SPN-2 and SXP-1
proteins may provide excellent serodiagnostic tools, and
additional recombinant antigens are now available to
probe the pathways by which the immune response
causes chronic disease in infection. For each functional
protein which is characterized, a potential new drug
target emerges, and with the application of structural
biology to filarial proteins (14,126), the design of new
drugs on a rational basis will become possible. Several
of the new proteins discussed here have been suggested
as candidate vaccines for filariasis. Perhaps the
prospects for the ALT antigens are most promising,
as their larval-specific expression is unlikely to mean
that immunized patients will develop exacerbated
pathogenic responses to adult worms. In addition, the
ALT proteins have the advantage of being filarial-
specific, reducing the risk of damaging cross-reactivity
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to host or environmental antigens (127). Filariasis
immunology is thus well-poised to integrate genome-
led data into innovative research into one of the
world’s foremost parasitic diseases.
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